An Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, was held on Wednesday August 24, 2011 at 4.00 p.m, IVA Konferenscenter - Wenströmsalen, Grev Turegatan 16, Stockholm.
The board of directors' proposal re a performance based, long-term share program for the CEO (the "CEO Share Program 2011")
The board of directors' proposal for resolutions on a) an authorization to issue series C shares, b) an authorization to repurchase series C shares, and c) the transfer of own shares under the CEO Share Program 2011